NASDAQ:CRBP - Corbus Pharmaceuticals SEC Filings & 10K Form

$6.05
-0.15 (-2.42 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$6.04
Now: $6.05
$6.31
50-Day Range
$6.10
MA: $6.86
$7.36
52-Week Range
$4.50
Now: $6.05
$9.11
Volume483,320 shs
Average Volume1.25 million shs
Market Capitalization$389.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

SEC Filings

Corbus Pharmaceuticals (NASDAQ:CRBP) SEC Filings

DateFilerForm TypeView
06/28/2019
3:06 PM
Corbus Pharmaceuticals (Issuer)
Panayiotopoulos Paris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2019
3:05 PM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2019
3:05 PM
Corbus Pharmaceuticals (Issuer)
Jacques Rachelle Suzanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2019
3:04 PM
Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/03/2019
3:54 PM
Corbus Pharmaceuticals (Subject)
ETF MANAGERS GROUP, LLC (Filed by)
Form SC 13G/A
View Filing
05/23/2019
7:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/20/2019
8:48 AM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2019
8:56 AM
Corbus Pharmaceuticals (Issuer)
Millian Craig Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2019
12:33 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2019
8:47 AM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/09/2019
7:04 AM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2019
6:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/29/2019
11:30 AM
Corbus Pharmaceuticals (Subject)
ETF MANAGERS GROUP, LLC (Filed by)
Form SC 13G/A
View Filing
04/18/2019
8:18 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2019
3:06 PM
Corbus Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/10/2019
3:05 PM
Corbus Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/08/2019
3:41 PM
Corbus Pharmaceuticals (Issuer)
Jacques Rachelle Suzanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/08/2019
3:40 PM
Corbus Pharmaceuticals (Issuer)
Jacques Rachelle Suzanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/08/2019
3:05 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/01/2019
3:05 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
8:46 AM
Corbus Pharmaceuticals (Issuer)
Hochman David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
10:09 AM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
9:32 AM
Corbus Pharmaceuticals (Issuer)
Millian Craig Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
1:35 PM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
12:07 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
10:25 AM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2019
8:02 PM
Corbus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/12/2019
8:26 AM
Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/12/2019
6:45 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/04/2019
5:44 PM
Corbus Pharmaceuticals (Issuer)
Millian Craig Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/04/2019
5:43 PM
Corbus Pharmaceuticals (Issuer)
Millian Craig Stuart (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/04/2019
7:37 AM
Corbus Pharmaceuticals (Filer)
Form CT ORDER
View Filing
02/19/2019
9:27 AM
Corbus Pharmaceuticals (Subject)
ETF MANAGERS GROUP, LLC (Filed by)
Form SC 13G/A
View Filing
02/14/2019
3:11 PM
Corbus Pharmaceuticals (Subject)
Tepper Mark (Filed by)
Form SC 13G/A
View Filing
02/14/2019
6:00 AM
Corbus Pharmaceuticals (Subject)
Knoll Capital Management, LP (Filed by)
Form SC 13G/A
View Filing
01/30/2019
8:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/28/2019
3:02 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
View Filing
01/25/2019
3:01 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/24/2019
3:19 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
View Filing
01/18/2019
3:59 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/18/2019
3:58 PM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/18/2019
3:57 PM
Corbus Pharmaceuticals (Issuer)
Tepper Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/18/2019
3:56 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2019
9:05 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/04/2018
3:58 PM
Corbus Pharmaceuticals (Filer)
Form CT ORDER
View Filing
11/16/2018
3:09 PM
Corbus Pharmaceuticals (Issuer)
Tepper Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/08/2018
7:01 AM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/08/2018
6:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
10:43 AM
Corbus Pharmaceuticals (Subject)
ETF MANAGERS GROUP, LLC (Filed by)
Form SC 13G
View Filing
09/20/2018
7:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/08/2018
8:22 AM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2018
8:10 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/25/2018
8:25 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/13/2018
8:29 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/06/2018
7:43 AM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/06/2018
7:40 AM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/06/2018
6:32 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2018
3:11 PM
Corbus Pharmaceuticals (Issuer)
Panayiotopoulos Paris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
3:07 PM
CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2018
12:16 PM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2018
7:46 AM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2018
1:07 PM
Corbus Pharmaceuticals (Issuer)
Hochman David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2018
9:58 AM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2018
3:39 PM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/10/2018
7:20 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/25/2018
12:51 PM
Corbus Pharmaceuticals (Filer)
Form CT ORDER
View Filing
04/13/2018
7:35 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/13/2018
7:30 AM
Corbus Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/16/2018
4:21 PM
Corbus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/15/2018
9:42 AM
Corbus Pharmaceuticals (Issuer)
Hochman David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2018
9:18 AM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2018
8:48 AM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
10:01 AM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2018
7:46 AM
Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
7:15 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
3:03 PM
Corbus Pharmaceuticals (Subject)
Knoll Capital Management, LP (Filed by)
Form SC 13G/A
View Filing
02/14/2018
2:53 PM
Corbus Pharmaceuticals (Subject)
Tepper Mark (Filed by)
Form SC 13G/A
View Filing
01/30/2018
6:10 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/17/2018
11:15 PM
Corbus Pharmaceuticals (Filer)
Form EFFECT
View Filing
01/17/2018
4:15 PM
Corbus Pharmaceuticals (Filer)
Form 424B3
View Filing
01/08/2018
8:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
4:30 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
4:29 PM
Corbus Pharmaceuticals (Issuer)
White Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
4:28 PM
Corbus Pharmaceuticals (Issuer)
Tepper Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
4:28 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
4:27 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
4:07 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
4:04 PM
Corbus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
This page was last updated on 7/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel